Micropulse diode vs conventional green laser treatment in clinically significant diabetic macular oedema

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN90646644

Enrollment

100

Registered

2007-08-30

Start date

2005-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic macular oedema Eye Diseases Retinal disorders in diseases classified elsewhere

Interventions

Micropulse diode vs conventional green laser treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with clinically significant macular edema due to diabetes in at least one eye 2. Able to understand and consent to the study 3. Vision acuity on study eye better than 20/200

Exclusion criteria

Exclusion criteria: 1. Ocular surgery within the past 6 months 2. Any laser surgery in the study eye 3. Any other ocular diseases in the study eye that can alter vision during the study period 4. Poor diabetic control with HBA1c >12

Design outcomes

Primary

Measure	Time frame
Visual acuity at 12 months.	—

Secondary

Measure	Time frame
The following will be assessed at 12 months: 1. Contract sensitivity 2. Central retinal thickness 3. Visible laser scars in macula	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026